1. Home
  2. Analysis
  3. Benzonatate
  4. Tretinoin

Benzonatate and Tretinoin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate and Tretinoin. Common interactions include renal failure among females and hypothyroidism among males.

The phase IV clinical study analyzes what interactions people who take Benzonatate and Tretinoin have. It is created by eHealthMe based on reports of 47 people who take Benzonatate and Tretinoin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 27, 2022

47 people who take Benzonatate and Tretinoin together, and have interactions are studied.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 14,176 Benzonatate users for its effectiveness, alternative drugs and more.

What is Tretinoin?

Tretinoin has active ingredients of tretinoin. It is often used in acne. eHealthMe is studying from 5,058 Tretinoin users for its effectiveness, alternative drugs and more.

Number of Benzonatate and Tretinoin reports submitted per year:

Benzonatate and Tretinoin drug interactions.

Common Benzonatate and Tretinoin drug interactions by gender *:

female:

  1. Renal failure
  2. Sepsis
  3. Abdominal pain upper
  4. Abscess limb
  5. Alanine aminotransferase increased
  6. Alopecia
  7. Anxiety
  8. Arthralgia
  9. Arthropathy
  10. Aspartate aminotransferase increased

male:

  1. Hypothyroidism
  2. Diabetes mellitus non-insulin-dependent
  3. Asthenia
  4. Denervation atrophy
  5. Difficulty in walking
  6. Disease progression
  7. Fall
  8. Muscle atrophy
  9. Muscle cramp
  10. Muscle weakness

Common Benzonatate and Tretinoin drug interactions by age *:

0-1:

  1. Activities of daily living impaired
  2. Anhedonia
  3. Anxiety
  4. Balance disorder
  5. Extrapyramidal disorder
  6. Injury
  7. Muscle spasms
  8. Myoclonus
  9. Neuropathy peripheral
  10. Osteoarthritis

2-9:

n/a

10-19:

  1. Abdominal discomfort
  2. Deep vein thrombosis
  3. Dyspnoea
  4. Headache
  5. Hypoaesthesia
  6. Nausea
  7. Oedema peripheral
  8. Overdose
  9. Pain
  10. Pain in extremity

20-29:

n/a

30-39:

  1. Anxiety
  2. Deep vein thrombosis
  3. Emotional distress
  4. General physical health deterioration
  5. Injury
  6. Pain
  7. Pulmonary embolism
  8. Pulmonary hypertension
  9. Pulmonary infarction
  10. Right ventricular hypertrophy

40-49:

  1. Foot deformity
  2. Gastrointestinal disorder
  3. Glycosuria
  4. Haematoma
  5. Hypercholesterolaemia
  6. Hypertension
  7. Hypoaesthesia
  8. Hyporeflexia
  9. Insomnia
  10. Malaise

50-59:

  1. Sepsis
  2. Asthma
  3. Chronic kidney disease
  4. Groin abscess
  5. Abscess limb
  6. Anhedonia
  7. Anxiety
  8. Drug ineffective
  9. Emotional distress
  10. Erythema

60+:

  1. Chronic kidney disease
  2. Metastatic malignant melanoma
  3. Metastases to lymph nodes
  4. Nephrogenic anaemia
  5. Nephrolithiasis
  6. Pneumonia
  7. Respiratory failure
  8. Trigger finger
  9. Renal failure
  10. Alopecia

Common conditions people have *:

  1. Pain: 10 people, 21.28%
  2. Asthma: 9 people, 19.15%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 19.15%
  4. High Blood Cholesterol: 8 people, 17.02%
  5. Stress And Anxiety: 7 people, 14.89%
  6. High Blood Pressure: 7 people, 14.89%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 12.77%
  8. Depression: 6 people, 12.77%
  9. Hypokalemia (low potassium): 6 people, 12.77%
  10. Type 2 Diabetes: 6 people, 12.77%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Tretinoin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Benzonatate and Tretinoin interactions:

Browse all drug interactions of Benzonatate and Tretinoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Benzonatate side effects:

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tretinoin side effects:

Browse all side effects of Tretinoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Benzonatate interactions:

Browse all interactions between Benzonatate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tretinoin interactions:

Browse all interactions between Tretinoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate and tretinoin (the active ingredients of Benzonatate and Tretinoin, respectively), and Benzonatate and Tretinoin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Benzonatate and Tretinoin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.